Circulating Endothelial Cells in Refractory Pulmonary Hypertension in Children: Markers of Treatment Efficacy and Clinical Worsening

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Levy, Marilyne ^a,b   Bonnet, Damien ^a,b   Mauge, Laetitia ^a,c,d   Celermajer, David S ^e   Gaussem, Pascale ^a,c,d   Smadja, David M ^a,c,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c INSERM   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CD146 ANTIGEN; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; SILDENAFIL; TREPROSTINIL;

ADOLESCENT; ARTICLE; BLOOD; BLOOD SAMPLING; CELL COUNT; CHILD; CIRCULATING ENDOTHELIUM CELL; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SCHOOL CHILD; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; IMMUNOMAGNETIC SEPARATION; INFANT; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PROSPECTIVE STUDIES; RECEPTORS, ENDOTHELIN; SEVERITY OF ILLNESS INDEX; VASCULAR RESISTANCE; VASODILATOR AGENTS; YOUNG ADULT;

EID: 84878829304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065114     Document Type: Article

References (37)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, et al. (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54: S43-54.
2. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, et al. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34: 1219-1263.
3. Berger RM, Bonnet D, (2010) Treatment options for paediatric pulmonary arterial hypertension. Eur Respir Rev 19: 321-330.
4. O'Callaghan DS, Savale L, Jais X, Natali D, Montani D, et al. (2010) Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension. Respir Med 104Suppl 1: S74-80.
5. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, et al. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30: 2493-2537.
6. Hoeper MM, Markevych I, Spiekerkoetter E, Welte T, Niedermeyer J, (2005) Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J 26: 858-863.
7. Levy M, Celermajer DS, Bourges-Petit E, Del Cerro MJ, Bajolle F, et al. (2011) Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension. J Pediatr 158: 584-588.
8. Smadja DM, Gaussem P, Mauge L, Israel-Biet D, Dignat-George F, et al. (2009) Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 119: 374-381.
9. Bull TM, Golpon H, Hebbel RP, Solovey A, Cool CD, et al. (2003) Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 90: 698-703.
10. Smadja DM, Mauge L, Sanchez O, Silvestre JS, Guerin C, et al. (2010) Distinct patterns of circulating endothelial cells in pulmonary hypertension. Eur Respir J 36: 1284-1293.
11. Widemann A, Sabatier F, Arnaud L, Bonello L, Al-Massarani G, et al. (2008) CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells. J Thromb Haemost 6: 869-876.
12. Woywodt A, Blann AD, Kirsch T, Erdbruegger U, Banzet N, et al. (2006) Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J Thromb Haemost 4: 671-677.
13. Izikki M, Guignabert C, Fadel E, Humbert M, Tu L, et al. (2009) Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J Clin Invest 119: 512-523.
14. Humbert M, Montani D, Perros F, Dorfmuller P, Adnot S, et al. (2008) Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascul Pharmacol 49: 113-118.
15. Chan SY, Loscalzo J, (2008) Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol 44: 14-30.
16. Farber HW, Loscalzo J, (2004) Pulmonary arterial hypertension. N Engl J Med 351: 1655-1665.
17. Levy M, Maurey C, Celermajer DS, Vouhe PR, Danel C, et al. (2007) Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. J Am Coll Cardiol 49: 803-810.
18. Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F, (2009) Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med 13: 454-471.
19. Garbuzova-Davis S, Woods RL 3rd, Louis MK, Zesiewicz TA, Kuzmin-Nichols N, et al (2010) Reduction of circulating endothelial cells in peripheral blood of ALS patients. PLoS One 5: e10614.
20. Smadja DM, Mauge L, Nunes H, d'Audigier C, Juvin K, et al. (2013) Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis. Angiogenesis 16: 147-157.
21. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, et al. (1998) Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 101: 927-934.
22. Rai PR, Cool CD, King JA, Stevens T, Burns N, et al. (2008) The cancer paradigm of severe pulmonary arterial hypertension. Am J Respir Crit Care Med 178: 558-564.
23. Delorme B, Basire A, Gentile C, Sabatier F, Monsonis F, et al. (2005) Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 94: 1270-1279.
24. Smadja DM, Mauge L, Gaussem P, d'Audigier C, Israel-Biet D, et al. (2011) Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension. Angiogenesis 14: 17-27.
25. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, et al. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801-1809.
26. Smadja DM, Bieche I, Silvestre JS, Germain S, Cornet A, et al. (2008) Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol 28: 2137-2143.
27. Smadja DM, Bieche I, Uzan G, Bompais H, Muller L, et al. (2005) PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol 25: 2321-2327.
28. Beghetti M, Galie N, (2009) Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J Am Coll Cardiol 53: 733-740.
29. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, et al. (2005) Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 93: 228-235.
30. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, et al. (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43: 13S-24S.
31. Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, et al. (2000) Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 157: 1703-1711.
32. Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, et al. (2005) Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol 145: 323-333.
33. Wort SJ, Woods M, Warner TD, Evans TW, Mitchell JA, (2001) Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling. Am J Respir Cell Mol Biol 25: 104-110.
34. Celermajer DS, Cullen S, Deanfield JE, (1993) Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 87: 440-446.
35. Cordina RL, Celermajer DS, (2010) Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension. Eur Respir Rev 19: 300-307.
36. Wort SJ, Mitchell JA, Woods M, Evans TW, Warner TD, (2000) The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol 36: S410-413.
37. Rizzo NO, Maloney E, Pham M, Luttrell I, Wessells H, et al. (2010) Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Arterioscler Thromb Vasc Biol 30: 758-765.